IL17A and psoriasis: Although the exact pathogenesis of psoriasis remains incompletely understood, accumulating evidence highlights the interleukin-23 (IL-23)/interleukin-17(IL-17) signaling axis as a central driver of disease initiation and progression (Bugaut and Aractingi, 2021).